Mc Carthy Asset Management, Inc. Cyto Dyn Inc. Transaction History

Mc Carthy Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.27 - $2.46 $5,461 - $10,578	-4,300 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$1.67 - $3.98 $1,377 - $3,283	-825 Reduced 16.1%	4,300 $7,000
Q1 2021 May 13, 2021	SELL	$2.12 - $7.15 $201 - $679	-95 Reduced 1.82%	5,125 $14,000
Q4 2020 Feb 01, 2021	BUY	$2.02 - $6.0 $10,544 - $31,320	5,220 New	5,220 $28,000

269K

Ticker CYDY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 813,040,000
Market Cap $203M
Description
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.